DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+19.07%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$2.81B
AUM Growth
-$7.23M
(-0.26%)
Cap. Flow
-$616M
Cap. Flow
% of AUM
-21.93%
Top 10 Holdings %
Top 10 Hldgs %
28.25%
Holding
132
New
16
Increased
23
Reduced
29
Closed
15
Top Buys
| 1 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$54.6M |
| 2 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$54.4M |
| 3 |
Tandem Diabetes Care
TNDM
|
$49.7M |
| 4 |
Xeris Biopharma Holdings
XERS
|
$47.4M |
| 5 |
Sarepta Therapeutics
SRPT
|
$39.1M |
Top Sells
| 1 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$93.4M |
| 2 |
DexCom
DXCM
|
$46M |
| 3 |
Natera
NTRA
|
$39.5M |
| 4 |
Glaukos
GKOS
|
$36.1M |
| 5 |
Centene
CNC
|
$32.5M |
Sector Composition
| 1 | Healthcare | 74.9% |
| 2 | Financials | 2.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARNA
51
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $17.4M | 0.61% |
398,194
-299,000
| -43% | -$13M |
|
|
OXFD
52
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $16.9M | 0.59% |
1,311,000
-133,000
| -9% | -$1.71M |
|
|
AVDL
53
Avadel Pharmaceuticals
AVDL
$1.45B
| $16.7M | 0.59% |
2,722,241
-1,066,299
| -28% | -$6.54M |
|
54
CytomX Therapeutics
CTMX
$350M
| $16.7M | 0.59% |
729,948
-23,374
| -3% | -$534K |
|
55
Molina Healthcare
MOH
$9.6B
| $16.5M | 0.58% |
168,000
| – | – |
|
|
BHVN
56
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $15.7M | 0.55% |
398,000
-471,000
| -54% | -$18.6M |
|
|
57
DexCom
DXCM
$30.9B
| $15.7M | 0.55% |
660,700
-1,935,300
| -75% | -$46M |
|
58
Galapagos
GLPG
$2.06B
| $15.2M | 0.53% |
165,000
+35,000
| +27% | +$3.23M |
|
59
Alnylam Pharmaceuticals
ALNY
$58.6B
| $14.4M | 0.51% |
146,000
| – | – |
|
|
NVTA
60
DELISTED
Invitae Corporation
NVTA
| $14M | 0.49% |
1,901,788
| – | – |
|
61
Zimmer Biomet
ZBH
$20.8B
| $13.5M | 0.47% |
124,630
| – | – |
|
62
Synlogic
SYBX
$17.4M
| $13.4M | 0.47% |
91,010
| – | – |
|
|
SYRS
63
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $13M | 0.46% |
126,895
| – | – |
|
64
Ardelyx
ARDX
$1.57B
| $12.9M | 0.45% |
3,491,922
+889,189
| +34% | +$3.29M |
|
|
SIEN
65
DELISTED
Sientra, Inc.
SIEN
| $12.7M | 0.44% |
64,910
+53,910
| +490% | +$10.5M |
|
|
GTHX
66
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $12.5M | 0.44% |
287,000
-86,000
| -23% | -$3.74M |
|
|
FTSV
67
DELISTED
Forty Seven, Inc. Common Stock
FTSV
| $9.6M | 0.34% |
+600,000
| New | +$9.6M |
|
68
Prothena Corp
PRTA
$452M
| $9.16M | 0.32% |
+628,262
| New | +$9.16M |
|
|
IVTY
69
DELISTED
Invuity, Inc
IVTY
| $9.11M | 0.32% |
2,336,889
| – | – |
|
|
WMGI
70
DELISTED
Wright Medical Group Inc
WMGI
| $9.07M | 0.32% |
349,539
-284,461
| -45% | -$7.38M |
|
71
Regenxbio
RGNX
$498M
| $8.97M | 0.32% |
125,000
-131,300
| -51% | -$9.42M |
|
|
TBIO
72
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $8.22M | 0.29% |
+650,000
| New | +$8.22M |
|
73
electroCore
ECOR
$38.8M
| $7.02M | 0.25% |
+28,362
| New | +$7.02M |
|
|
ALPN
74
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $6.91M | 0.24% |
913,100
| – | – |
|
75
Option Care Health
OPCH
$4.7B
| $6.84M | 0.24% |
583,750
-197,250
| -25% | -$2.31M |
|